Nan Fung Group's investment focus extends beyond its core property development business to include diversified venture capital activities in innovation, techstyle, life sciences, healthcare, and elderly care. Through its financial investment arm, Nan Fung Trinity, and specialized funds like The Mills Fabrica Fund, the group invests across various asset classes, including global techstyle startups and companies in healthcare and medical devices.
100% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-b (50% of deals).
Portfolio
2
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 FogPharma | Series B | $66M | May 2018 |
 Bolt Threads | Series C | $50M | May 2016 |
Top Co-Investors
GV (Google Ventures)1 shared
Blue Pool Capital1 shared
Horizon Ventures1 shared
Deerfield1 shared
Boyu Capital1 shared
Formation 81 shared
Innovation Endeavors1 shared
Foundation Capital1 shared
Founders Fund1 shared
Last updated: 28 April 2026